LAK cells, generated by culturing blood lymphocytes with high dose IL-2, are also able to lyse tumor cells in a non-MHC-restricted manner and have been applied in vivo for the treatment of various tumors [26–29]. This evidence concerns the gene IL2 and neoplasm.